Pugazhenthi S, Khandelwal R L, Angel J F
Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.
Biochim Biophys Acta. 1991 Jun 3;1083(3):310-2. doi: 10.1016/0005-2760(91)90088-y.
The effect of oral administration of sodium orthovanadate on hepatic malic enzyme (EC 1.1.1.40) and glucose-6-phosphate dehydrogenase (EC 1.1.1.49) activities was investigated in nondiabetic and diabetic rats. Streptozotocin-induced diabetic rats were characterized by 4.7-fold increase in plasma glucose and 82% decrease in plasma insulin levels. The activities of hepatic malic enzyme and glucose-6-phosphate dehydrogenase were also diminished (P less than 0.001). Vanadate treatment in diabetic rats led to a significant decrease (P less than 0.001) in plasma glucose levels and to the normalization of enzyme activities, but it did not alter plasma insulin levels. In nondiabetic rats vanadate decreased the plasma insulin level by 64% without altering the enzyme activities. Significant correlation was observed between plasma insulin and hepatic lipogenic enzyme activities in untreated and vanadate-treated rats. Vanadate administration caused a shift to left in this correlation suggesting improvement in insulin sensitivity.
在非糖尿病和糖尿病大鼠中研究了口服原钒酸钠对肝脏苹果酸酶(EC 1.1.1.40)和葡萄糖-6-磷酸脱氢酶(EC 1.1.1.49)活性的影响。链脲佐菌素诱导的糖尿病大鼠表现为血糖水平升高4.7倍,血浆胰岛素水平降低82%。肝脏苹果酸酶和葡萄糖-6-磷酸脱氢酶的活性也降低(P<0.001)。糖尿病大鼠的钒酸盐治疗导致血糖水平显著降低(P<0.001),酶活性恢复正常,但未改变血浆胰岛素水平。在非糖尿病大鼠中,钒酸盐使血浆胰岛素水平降低了64%,而未改变酶活性。在未治疗和钒酸盐治疗的大鼠中,血浆胰岛素与肝脏脂肪生成酶活性之间存在显著相关性。钒酸盐给药导致这种相关性向左移动,表明胰岛素敏感性得到改善。